Cargando…
Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
The Middle East respiratory syndrome coronavirus (MERS-CoV) is associated with life-threatening severe illnesses and a mortality rate of approximately 35%, particularly in patients with underlying comorbidities. A systematic analysis of 637 MERS-CoV cases suggests that diabetes and hypertension are...
Autores principales: | Badawi, Alaa, Ryoo, Seung Gwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110556/ https://www.ncbi.nlm.nih.gov/pubmed/27352628 http://dx.doi.org/10.1016/j.ijid.2016.06.015 |
Ejemplares similares
-
Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis
por: Badawi, Alaa, et al.
Publicado: (2016) -
The role of diabetes in the severity of 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis
por: Badawi, A., et al.
Publicado: (2016) -
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017) -
Healthcare worker exposure to Middle East respiratory syndrome coronavirus (MERS-CoV): Revision of screening strategies urgently needed
por: Amer, Hala, et al.
Publicado: (2018) -
Middle East respiratory syndrome coronavirus (MERS-CoV)
Publicado: (2019)